Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Sotatercept
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[2] 86, 284 💬
2Sotatercept - 45 mg/vial
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
3Sotatercept - 60 mg/vial
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
4Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962 Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962 Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 55-
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
5Sotatercept - 60 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 72.5-Product Name: Sotatercept - 45 mg/vialProduct Code: ACE-011 / MK-7962Pharmaceutical Form: Lyophilisate for solution for injectionINN or Proposed INN: SOTATERCEPTCAS Number: 1001080-50-7Current Sponsor code: ACE-011 / MK-7962Other descriptive name: ActRIIA-IgG1FcConcentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 55-
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
6Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg
(D09670)
[1] Sotatercept[1] Sotatercept (D09670) 💬 [1] ACVR2A 💬 [4] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 86 💬
7Sotatercept with prednisone boost
(D09670)
[2] Prednisone,
Sotatercept
[2] Prednisone ,
Sotatercept (D09670) 💬
[2] ACVR2A,
NR3C1 💬
[5] Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Neuroactive ligand-receptor interaction, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬[1] 284 💬